HEUKING advises Berlin-based HealthTech start-up hellomed on its seed II financing round
The venture capital (VC) team led by Düsseldorf-based HEUKING partner Dr. Patrick Müller provided legal advice to the HealthTech start-up hellomed Group GmbH in a successful Seed II financing round. hellomed raised a total of around €6 million, which will be used to expand its digital medication management solution (hellomedOS). The aim is to prevent medication errors in outpatient and inpatient care while also reducing the workload of nursing staff so that they can spend more time working directly with patients.
hellomed Group GmbH, based in Berlin, was founded by Enrico Bernardo, Felix Morawski, and Tim Bogdan and is developing hellomedOS, a software solution for quality-assured medication management in outpatient and inpatient care. With hellomedOS, hellomed is digitizing particularly error-prone, system-relevant processes between care companies, pharmacies, patients, and relatives. The aim is to increase medication safety, noticeably reduce the workload on nursing staff, and reduce avoidable follow-up costs in the healthcare system.
HEUKING regularly advises start-ups and VC investors on funding rounds. The team led by Dr. Patrick Müller had previously advised hellomed in June on a late seed funding round and a related share capital increase.
Counsel to hellomed Group GmbH
HEUKING:
Dr. Patrick Müller, LL.M. (University of the West of England, Bristol), (Lead), Düsseldorf,
Ilona Schütz, Düsseldorf/Cologne,
Caroline Frohnwieser, Hamburg,
Laura Jochem, LL.M. (University of East Anglia, Norwich), (all Venture Capital), Düsseldorf
